Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries

In a Perspective for the Tuberculosis Special Issue, Kevin Schwartzman and colleagues discuss the choices and implications for personal versus public health benefits when pursuing tuberculosis elimination in low-incidence countries.

Detalles Bibliográficos
Autores principales: Campbell, Jonathon R., Dowdy, David, Schwartzman, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553715/
https://www.ncbi.nlm.nih.gov/pubmed/31170161
http://dx.doi.org/10.1371/journal.pmed.1002824
_version_ 1783424860751396864
author Campbell, Jonathon R.
Dowdy, David
Schwartzman, Kevin
author_facet Campbell, Jonathon R.
Dowdy, David
Schwartzman, Kevin
author_sort Campbell, Jonathon R.
collection PubMed
description In a Perspective for the Tuberculosis Special Issue, Kevin Schwartzman and colleagues discuss the choices and implications for personal versus public health benefits when pursuing tuberculosis elimination in low-incidence countries.
format Online
Article
Text
id pubmed-6553715
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65537152019-06-17 Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries Campbell, Jonathon R. Dowdy, David Schwartzman, Kevin PLoS Med Policy Forum In a Perspective for the Tuberculosis Special Issue, Kevin Schwartzman and colleagues discuss the choices and implications for personal versus public health benefits when pursuing tuberculosis elimination in low-incidence countries. Public Library of Science 2019-06-06 /pmc/articles/PMC6553715/ /pubmed/31170161 http://dx.doi.org/10.1371/journal.pmed.1002824 Text en © 2019 Campbell et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Policy Forum
Campbell, Jonathon R.
Dowdy, David
Schwartzman, Kevin
Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
title Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
title_full Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
title_fullStr Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
title_full_unstemmed Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
title_short Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
title_sort treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
topic Policy Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553715/
https://www.ncbi.nlm.nih.gov/pubmed/31170161
http://dx.doi.org/10.1371/journal.pmed.1002824
work_keys_str_mv AT campbelljonathonr treatmentoflatentinfectiontoachievetuberculosiseliminationinlowincidencecountries
AT dowdydavid treatmentoflatentinfectiontoachievetuberculosiseliminationinlowincidencecountries
AT schwartzmankevin treatmentoflatentinfectiontoachievetuberculosiseliminationinlowincidencecountries

Ejemplares similares